PREDICTIVE VALUE OF CA125, HE4 AND ROMA INDEX IN ENDOMETRIAL CANCER. PRELIMINARY RESULTS.

被引：0
|
作者：
Blontzos, N. [1 ]
Iavazzo, C. [1 ]
Galati, E. [1 ]
Vyllioti, V. [2 ]
Lamprou, E. [3 ]
Maliaros, A. [4 ]
Kalinoglou, N. [1 ]
Vorgias, G. [1 ]
机构：
[1] Metaxa Mem Canc Hosp, Gynecol Oncol, Piraeus, Greece
[2] Metaxa Mem Canc Hosp, Biochem Lab, Piraeus, Greece
[3] Metaxa Mem Canc Hosp, Biopathol Lab, Piraeus, Greece
[4] Metaxa Mem Canc Hosp, Biostat, Piraeus, Greece
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2017年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ESGO7-1293
引用
收藏
页码：1052 / 1052
页数：1
相关论文
共 50 条
  • [31] Diagnostic value of CA125, HE4, ROMA and logistic regression model in pelvic mass diagnostics - our experience
    Michalak, Marcin
    Gasiorowska, Emilia
    Markwitz, Ewa Nowak
    GINEKOLOGIA POLSKA, 2015, 86 (04) : 256 - 261
  • [32] The diagnosis and pathological value of combined detection of HE4 and CA125 for patients with ovarian cancer
    Zheng, Li-e
    Qu, Jun-ying
    He, Fei
    OPEN MEDICINE, 2016, 11 (01): : 125 - 132
  • [33] Preoperative HE4, CA125 and ROMA in the differential diagnosis of benign and malignant adnexal masses
    Terlikowska, Katarzyna M.
    Dobrzycka, Bozena
    Witkowska, Anna M.
    Mackowiak-Matejczyk, Beata
    Sledziewski, Tomasz Kamil
    Kinalski, Maciej
    Terlikowski, Slawomir J.
    JOURNAL OF OVARIAN RESEARCH, 2016, 9
  • [34] Preoperative HE4, CA125 and ROMA in the differential diagnosis of benign and malignant adnexal masses
    Katarzyna M. Terlikowska
    Bozena Dobrzycka
    Anna M. Witkowska
    Beata Mackowiak-Matejczyk
    Tomasz Kamil Sledziewski
    Maciej Kinalski
    Slawomir J. Terlikowski
    Journal of Ovarian Research, 9
  • [35] CA125 and HE4 levels in a Czech Female Population Diagnosed with Endometrial Cancer in Preoperative Management
    Presl, Jiri
    Novotny, Zdenek
    Topolcan, Ondrej
    Vlasak, Pavel
    Kucera, Radek
    Fuchsova, Radka
    Vrzalova, Jindra
    Betincova, Lucie
    Svobodova, Sarka
    ANTICANCER RESEARCH, 2014, 34 (1A) : 327 - 331
  • [36] The value of serum HE4 and CA125 levels for monitoring the recurrence and risk stratification of endometrial endometrioid carcinoma
    Gong, Sainan
    Quan, Quan
    Meng, Yu
    Wu, Jingxian
    Yang, Shuang
    Hu, Jiaming
    Mu, Xiaoling
    HELIYON, 2023, 9 (07)
  • [37] Clinical factors affecting HE4 and CA125 in women at high risk of developing ovarian cancer.
    Raamanathan, Archana
    Holman, Laura L.
    Urbauer, Diana L.
    Baggerly, Keith A.
    Shen, Yu
    Bast, Robert C.
    Lu, Karen H.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [38] Value of HE4 combined with cancer Antigen 125 in the diagnosis of Endometrial Cancer
    Dong, Chunhua
    Liu, Ping
    Li, Chao
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2017, 33 (04) : 1013 - 1017
  • [39] Utility of HE4 and CA-125 as predictive and prognostic factors in preoperative assessment of endometrial cancer
    Gao, M.
    Zhang, N.
    Gao, Y.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 164 - 164
  • [40] The Prognostic and Predictive Value of Combined HE4 and CA-125 in Ovarian Cancer Patients
    Steffensen, Karina Dahl
    Waldstrom, Marianne
    Brandslund, Ivan
    Petzold, Max
    Jakobsen, Anders
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2012, 22 (09) : 1474 - 1482
12345